Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| AGTR1 | P30556 | Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1 receptor) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Alzheimer diseaseArteries/arterioles disorderEssential hypertension | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| AGTR2 | P50052 | Type-2 angiotensin II receptor (Angiotensin II type-2 receptor) (AT2 receptor) | 7 | HypertensionNeuropathySecondary hypertension | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.53 | |||
| AJM1 | C9J069 | Apical junction component 1 homolog | Predicted intracellular proteins | Fusion and delivery mediation | 1 | 0.53 | ||||
| AKA11 | Q9UKA4 | A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11) | Plasma proteinsPredicted intracellular proteins | Metabolism mediation | 1 | 0.53 | ||||
| AKA12 | Q02952 | A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||||
| AKAP5 | P24588 | A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 79 kDa) (AKAP 79) (H21) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein) | Plasma proteinsPredicted intracellular proteinsTransporters | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.53 | ||||
| AL3A1 | P30838 | Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (ALDHIII) (Aldehyde dehydrogenase 3) (Aldehyde dehydrogenase family 3 member A1) | EnzymesMetabolic proteinsPredicted intracellular proteins | Metabolism mediation | 1 | 0.53 | ||||
| AMPE | Q07075 | Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD antigen CD249) | CD markersEnzymesPlasma proteins | 1 | Hypertension | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.53 | ||
| AMPN | P15144 | Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13) | CD markersEnzymesMetabolic proteins | 1 | Psoriasis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| AN13A | Q8IZ07 | Ankyrin repeat domain-containing protein 13A (Protein KE03) | Predicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.53 |